Betoptic S is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Betaxolol Hydrochloride.
| Product ID | 0078-0729_905ba189-456c-4aa4-8231-39a971374ad8 |
| NDC | 0078-0729 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Betoptic S |
| Generic Name | Betaxolol Hydrochloride |
| Dosage Form | Suspension/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 1996-01-15 |
| Marketing Category | NDA / |
| Application Number | NDA019845 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | BETAXOLOL HYDROCHLORIDE |
| Active Ingredient Strength | 3 mg/mL |
| Pharm Classes | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-08-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0065-0246 | Betoptic S | betaxolol hydrochloride |
| 0078-0729 | Betoptic S | betaxolol hydrochloride |
| 17478-705 | Betaxolol | Betaxolol Hydrochloride |
| 10702-013 | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride |
| 10702-014 | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride |
| 61314-245 | Betaxolol Hydrochloride | Betaxolol Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BETOPTIC S 75359301 2248882 Live/Registered |
Novartis AG 1997-09-18 |